December 13, 2023
The U.S. Supreme Court said Wednesday that it would review a dispute over the abortion medication mifepristone, setting up a high court battle over a lower court judge's extraordinary decision to block the U.S. Food and Drug Administration's decades-old approval of the drug.
December 09, 2023
A former BigLaw partner in his 30s made history by joining a preeminent circuit court, a former BigLaw partner in his 50s made waves by leaving the largest circuit, and a former chemist in her 90s made enemies by resisting a probe on the most specialized circuit. That's a small sample of the intrigue that flourished in 2023 throughout the federal appellate system, where diversity bloomed and controversy abounded.
November 22, 2023
The U.S. Food and Drug Administration told the U.S. Supreme Court that a Fifth Circuit decision limiting access to the abortion medication mifepristone could create "profound disruption" for patients and medical professionals, joining a distributor of the drug in urging the justices to review the "unprecedented" decision.
November 16, 2023
A strong showing for abortion rights on Election Day did not dissuade 109 GOP lawmakers from asking the U.S. Supreme Court to pass on reviewing a Fifth Circuit decision that would curb access to the abortion drug mifepristone.
November 08, 2023
The federal government and a distributor of the abortion pill mifepristone urged the U.S. Supreme Court to reject an organization's argument over its challenge to the U.S. Food and Drug Administration's approval of the medication, saying that millions of women have used it to safely terminate pregnancies.
October 17, 2023
Anti-abortion activists are telling the U.S. Supreme Court that if the justices review parts of a Fifth Circuit ruling reinstating the approval of an abortion medication, they should consider the entire case.